These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 15049211)
21. Thalidomide in cancer medicine. Eleutherakis-Papaiakovou V; Bamias A; Dimopoulos MA Ann Oncol; 2004 Aug; 15(8):1151-60. PubMed ID: 15277253 [TBL] [Abstract][Full Text] [Related]
22. [An old drug as a carcinostatic. The new career of thalidomide]. Holzgrabe U Pharm Unserer Zeit; 2007; 36(6):446-9. PubMed ID: 17957689 [TBL] [Abstract][Full Text] [Related]
23. Thalidomide. A new beginning. Valorie AM Cancer Pract; 2000; 8(2):101-3. PubMed ID: 11898173 [No Abstract] [Full Text] [Related]
24. Is thalidomide a true anti-angiogenic molecule in multiple myeloma? Ribatti D; Vacca A Haematologica; 2002 Apr; 87(4):344-5. PubMed ID: 11940476 [No Abstract] [Full Text] [Related]
25. The evolution of thalidomide and its IMiD derivatives as anticancer agents. Bartlett JB; Dredge K; Dalgleish AG Nat Rev Cancer; 2004 Apr; 4(4):314-22. PubMed ID: 15057291 [No Abstract] [Full Text] [Related]
26. Thalidomide in the treatment of multiple myeloma. Kastritis E; Dimopoulos MA Best Pract Res Clin Haematol; 2007 Dec; 20(4):681-99. PubMed ID: 18070713 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms of action and potential therapeutic uses of thalidomide. Mujagić H; Chabner BA; Mujagić Z Croat Med J; 2002 Jun; 43(3):274-85. PubMed ID: 12035132 [TBL] [Abstract][Full Text] [Related]
28. [New treatment strategy of multiple myeloma for cure]. Murakami H; Handa H Gan To Kagaku Ryoho; 2006 Apr; 33(4):417-23. PubMed ID: 16612147 [TBL] [Abstract][Full Text] [Related]
30. [Multiple myeloma: the role of angiogenesis and therapeutic application of thalidomide]. Jurczyszyn A; Wolska-Smoleń T; Skotnicki AB Przegl Lek; 2003; 60(8):542-7. PubMed ID: 14974349 [TBL] [Abstract][Full Text] [Related]
31. Thalidomide: mechanisms of action. Paravar T; Lee DJ Int Rev Immunol; 2008; 27(3):111-35. PubMed ID: 18437602 [TBL] [Abstract][Full Text] [Related]
32. Thalidomide--a revival story. Raje N; Anderson K N Engl J Med; 1999 Nov; 341(21):1606-9. PubMed ID: 10564693 [No Abstract] [Full Text] [Related]
33. Thalidomide, the FDA, and us -- what do you have? Underground compassionate use. Food and Drug Administration. Notes Undergr; 1995; (no 29):1-3, 8. PubMed ID: 11362280 [TBL] [Abstract][Full Text] [Related]
34. Neuropathy in multiple myeloma treated with thalidomide: a prospective study. Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA Neurology; 2007 Aug; 69(6):573-81. PubMed ID: 17679676 [TBL] [Abstract][Full Text] [Related]
35. Thalidomide: a re-look. Grover JK; Vats V; Gopalakrishna R; Ramam M Natl Med J India; 2000; 13(3):132-41. PubMed ID: 11558112 [TBL] [Abstract][Full Text] [Related]
36. Thalidomide as a novel therapeutic agent: new uses for an old product. Teo SK; Stirling DI; Zeldis JB Drug Discov Today; 2005 Jan; 10(2):107-14. PubMed ID: 15718159 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic renaissance of thalidomide in the treatment of haematological malignancies. Ribatti D; Vacca A Leukemia; 2005 Sep; 19(9):1525-31. PubMed ID: 15973447 [TBL] [Abstract][Full Text] [Related]
38. Thalidomide: when everything old is new again. Nirenberg A Clin J Oncol Nurs; 2001; 5(1):15-8. PubMed ID: 11899395 [TBL] [Abstract][Full Text] [Related]
39. The thalidomide saga. Melchert M; List A Int J Biochem Cell Biol; 2007; 39(7-8):1489-99. PubMed ID: 17369076 [TBL] [Abstract][Full Text] [Related]
40. [Bone marrow angiogenesis in multiple myeloma: new insights into the pathogenesis, and development of a new therapeutic approach]. Hattori Y; Kakimoto T Rinsho Ketsueki; 2000 May; 41(5):426-9. PubMed ID: 10879105 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]